Omega-3 PUFA 的全球市場

到 2030 年，全球Omega-3 PUFA 市場預計將達到 182 億美元

Omega-3 PUFA 的全球市場預計 2023 年為 83 億美元，預計到 2030 年將達到 182 億美元，2023 年至 2030 年複合年成長率為 11.9%。二十二碳六烯酸 (DHA) 是本報告分析的細分市場之一，預計複合年成長率為 9.8%，到分析期結束時將達到 87 億美元。預計未來七年二十碳五烯酸 (EPA) 領域的複合年成長率為 14.6%。

美國市場預計將成長22億美元，中國複合年成長率為15.3%

到 2023 年，美國Omega-3 PUFA 市場預計將達到 22 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達42億美元，2023年至2030年複合年成長率為15.3%。其他值得注意的區域市場包括日本和加拿大，預計 2023 年至 2030 年將分別成長 8.1% 和 9.8%。在歐洲，德國的複合年成長率預計約為 9.1%。以澳洲、印度和韓國等國家為首的亞太市場預計到2030年將達到29億美元。

2024 年推出令人興奮的新報告功能

完全訪問影響者參與統計數據

免費存取數位檔案和「MarketGlass」研究平台。我們獨特的 MarketGlass 平台能夠以整合和協作的方式釋放世界各地專家的創造力和市場知識。我們的尖端工具提供世界一流的市場可視性，同時保護市場參與企業的隱私和身分。報告中的數字、統計數據和市場描述是基於該領域專家和影響者共用的全面見解。

使用即時資料模擬器工具和客製化報告功能參與互動式調查。

客戶全面連結同儕協作互動平台，實現企業間智慧交流

1 年免費報告更新

競爭覆蓋範圍，包括主要參與者的全球市場佔有率

多個地區參與者的市場影響分析（強/活躍/利基/次要）

訪問專家/影響者訪談、播客、新聞稿和活動主題演講的 YouTube 影片

2024 年世界經濟有何預期

貨幣緊縮和相關利率上升導致的地緣政治和經濟不穩定將在 2024 年造成動盪的局面。一些因素將繼續給復甦之路帶來壓力，包括中東的敵對行動和日益頻繁的氣候災害。儘管存在風險，但一些積極因素正在顯現，包括通膨放緩的徵兆更加明顯、對頑固通膨的擔憂有所緩解、供應鏈正常化以及儘管能源成本出現波動但價格仍有所回落。印度和美國等二十一國集團國家的選舉可能會影響資本流動和投資策略。儘管印度作為全球投資目的地的地位日益突出，但在充滿活力的人才和資本生態系統的推動下，美國科技公司將繼續佔據主導地位。儘管該國經濟放緩，但由於國內經濟富有彈性和有利的法規環境，高科技機會（尤其是矽谷）仍然對尋求高成長潛力的投資者俱有吸引力。歐洲持續應對緊縮的貨幣政策和景氣衰退風險，但英國的前景最嚴峻，2024 年景氣衰退的風險最高。中國仍然是通用憑證，其成長預計將受到政府支出和消費者支出改善的支持。動盪的環境可能為投資者和公司帶來機會和挑戰。將波動性視為成長的催化劑，並以敏捷性和策略遠見來制定投資決策，對於生存仍然至關重要。

調查企業舉例（共11家）

• Arista Industries Inc.
• Cargill, Inc.
• Croda International PLC
• FMC Corporation
• Gc Rieber Oil
• Omega Protein Corporation
• Pharma Marine AS
• Polaris
• Royal DSM NV

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Omega-3 PUFA Market to Reach $18.2 Billion by 2030

The global market for Omega-3 PUFA estimated at US$8.3 Billion in the year 2023, is expected to reach US$18.2 Billion by 2030, growing at a CAGR of 11.9% over the analysis period 2023-2030. Docosahexaenoic Acid (DHA), one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$8.7 Billion by the end of the analysis period. Growth in the Eicosapentaenoic Acid (EPA) segment is estimated at 14.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 15.3% CAGR

The Omega-3 PUFA market in the U.S. is estimated at US$2.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 9.8% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.9 Billion by the year 2030.

Introducing Our Exciting New Report Features for 2024

Full access to influencer engagement stats

Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants' privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.

Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities

Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas

Complimentary report updates for one year

Competitor coverage with global market shares of major players

Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies

Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 11 Featured) -

• Arista Industries Inc.
• Cargill, Inc.
• Croda International PLC
• FMC Corporation
• Gc Rieber Oil
• Omega Protein Corporation
• Pharma Marine AS
• Polaris
• Royal DSM NV

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Omega-3 PUFA - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Omega-3 PUFA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Docosahexaenoic acid (DHA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Docosahexaenoic acid (DHA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Docosahexaenoic acid (DHA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Eicosapentaenoic acid (EPA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Eicosapentaenoic acid (EPA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Eicosapentaenoic acid (EPA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Alpha linoleic acid (ALA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Alpha linoleic acid (ALA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Alpha linoleic acid (ALA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Pet & Animal Feed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Pet & Animal Feed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 24: World 16-Year Perspective for Pet & Animal Feed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Marine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Marine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 30: World 16-Year Perspective for Marine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 33: World 16-Year Perspective for Plant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 34: World Omega-3 PUFA Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• JAPAN
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• CHINA
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: China 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: China 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: China 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• EUROPE
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Omega-3 PUFA by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• FRANCE
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: France 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: France 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: France 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• GERMANY
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Omega-3 PUFA by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• INDIA
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: India 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: India 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: India 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Omega-3 PUFA by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Omega-3 PUFA by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Omega-3 PUFA by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030
• AFRICA
  • Omega-3 PUFA Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Omega-3 PUFA by Type - Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Omega-3 PUFA by Type - Percentage Breakdown of Value Sales for Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA) and Alpha linoleic acid (ALA) for the Years 2014, 2024 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Omega-3 PUFA by Application - Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Omega-3 PUFA by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Infant Formula, Pharmaceuticals, Pet & Animal Feed and Other Applications for the Years 2014, 2024 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Omega-3 PUFA by Source - Marine and Plant - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Omega-3 PUFA by Source - Marine and Plant Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Omega-3 PUFA by Source - Percentage Breakdown of Value Sales for Marine and Plant for the Years 2014, 2024 & 2030

IV. COMPETITION